PRIMARY STUDY

Tetrahydrocannabinol (THC) Exacerbates Inflammatory Bowel Disease in Adolescent and Adult Female Rats

Key Findings:  This rat model of inflammatory bowel disease (IBD) found that tetrahydrocannabinol (THC) exacerbates the negative behavioral effects of IBD

Type of Study:  Animal Study

Study Result:  Negative

Study Location(s):  United States

Year of Pub:  2021


Cannabinoids Studied:  Tetrahydrocannabinol (THC)

Phytocannabinoid Source:  Unspecified

Chemotype:  Chemotype I

Dosage: THC (0.32 mg/kg)

Route of Administration:  Injection



Link to study